Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial
Author:
- The DREAM Trial InvestigatorsTIThe DREAM Trial Investigators
- 21 August 2004
- journal article
- clinical trial
- Published by Springer Nature in Diabetologia
- Vol. 47 (9) , 1519-1527
Abstract
Diabetes is a rapidly rising independent risk factor for atherosclerosis and serious illness. This risk can be reduced by lifestyle changes and/or various drugs. Novel therapies to prevent diabetes, as well as new risk factors for diabetes, atherosclerosis and obesity require testing and identification.Keywords
This publication has 34 references indexed in Scilit:
- Follow-up Report on the Diagnosis of Diabetes MellitusDiabetes Care, 2003
- Economic Costs of Diabetes in the U.S. in 2002Diabetes Care, 2003
- Is the Current Definition for Diabetes Relevant to Mortality Risk From All Causes and Cardiovascular and Noncardiovascular Diseases?Diabetes Care, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Dysglycemia: A Key Cardiovascular Risk FactorSeminars in Vascular Medicine, 2002
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- ACE Inhibitor Use Is Associated With Hospitalization for Severe Hypoglycemia in Patients With DiabetesDiabetes Care, 1997
- Impaired Glucose Tolerance is Normalized by Treatment With the Thiazolidinedione TroglitazoneDiabetes Care, 1997
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991